{
    "nctId": "NCT05285943",
    "briefTitle": "Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients",
    "officialTitle": "A Comparative Study Between Topical Betamethasone Cream or Topical Olive Oil Cream in Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients.",
    "overallStatus": "RECRUITING",
    "conditions": "Radiodermatitis; Acute",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 132,
    "primaryOutcomeMeasure": "Acute Radiation Dermatitis (ARD) grading",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histological confirmation of breast malignancy,\n* Surgical intervention for carcinoma of the breast with or without lymph node metastasis.\n* Treatment with planned course of radiation therapy 5 days a week for 3-6 weeks.\n* Good Eastern Cooperative Oncology Group (ECOG) performance status (0 or 1).\n* Total radiation dose of \u226542 Gy.\n\nExclusion Criteria:\n\n* Pregnant and lactating mothers.\n* Previous radiation to the chest or breast area.\n* Concomitant chemotherapy.\n* Concomitant medication that may cause skin reactions.\n* Use of any other product on the skin at the treatment site at any time of the study.\n* Active dermatitis, history of autoimmune and connective tissue diseases, skin inflammatory diseases or any other specific skin disease.\n* Treatment with local or oral corticosteroid, or antioxidant medications.\n* Allergy to olive oil.\n* Inflammatory carcinoma of the breast as well as those with a known allergy to olive oil.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}